Idiopathic Pulmonary Fibrosis
A large number of patients with diffuse interstitial lung disease will not fit into any of the previously mentioned categories. These patients, usually middle aged with no sex predominance, present with dyspnea and x-ray evidence of interstitial disease. Rarely, the disease progresses very rapidly to death from respiratory failure within six months of the onset of symptoms (Ham-man-Rich syndrome). When the disease is more slowly progressive, it is termed idiopathic pulmonary fibrosis or cryptogenic fibrosing alveolitis.
- HYPERKINETIC PULMONARY HYPERTENSION
- Idiopathic Pulmonary Fibrosis
- CLINICAL MANIFESTATIONS
- EFFECTS OF PULMONARY HYPERTENSION ON PULMONARY FUNCTION
- TREATMENT
- CLINICAL FEATURES OF PULMONARY HYPERTENSION
- OBLITERATIVE OR OBSTRUCTIVE PULMONARY HYPERTENSION
- EMBOLIC DISEASE
- DIFFUSE INFILTRATIVE DISEASES OF THE LUNG
- DIFFUSE LUNG DISEASE OF UNKNOWN ETIOLOGY
- PHYSIOLOGICAL EFFECTS OF PULMONARY HYPERTENSION ON CARDIAC FUNCTION
- CAUSES OF PULMONARY HYPERTENSION
- SPECIFIC ENTITIES - DISEASES WITH KFiOWIi ETIOLOGIES -
- Pulmonary Hemorrhagic Disorders
- Other Clearly Extrinsic Causes of Diffuse Infiltrative Lung Disease
- Hypersensitivity Pneumonitis
- Pulmonary Vasculitis
- Miscellaneous
- Sarcoidosis
- Pulmonary Infiltrates with Eosinophilia PIE
- POSTCAPILLARY PULMONARY HYPERTENSION